ID   OMA-AML-1
AC   CVCL_A110
DR   Cosmic; 787474
DR   Cosmic; 975296
DR   Cosmic; 1281351
DR   Wikidata; Q54932025
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1379848;
RX   PubMed=7517745;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7463; Acute myelomonocytic leukemia
DI   ORDO; Orphanet_517; Acute myelomonocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 10
//
RX   PubMed=1379848; DOI=10.1182/blood.V80.4.1026.1026;
RA   Pirruccello, Samuel Jay
RA   Jackson, John D.
RA   Lang, Molly S.
RA   DeBoer, Joanne M.
RA   Mann, Sally
RA   Crouse, David
RA   Vaughan, William P.
RA   Dicke, Karel A.
RA   Sharp, John Graham
RT   "OMA-AML-1: a leukemic myeloid cell line with CD34+ progenitor and
RT   CD15+ spontaneously differentiating cell compartments.";
RL   Blood 80:1026-1032(1992).
//
RX   PubMed=7517745; DOI=10.3109/10428199409051668;
RA   Pirruccello, Samuel Jay
RA   Jackson, John D.
RA   Sharp, John Graham
RT   "The leukemic myeloid cell line OMA-AML-1: an in vitro model of
RT   hematopoietic cell differentiation.";
RL   Leuk. Lymphoma 13:169-178(1994).
//
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RA   Drexler, Hans Gunther
RT   "The leukemia-lymphoma cell line factsbook.";
RL   (In book) ISBN 9780122219702; pp.1-733; Academic Press; London; United Kingdom (2001).
//